Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
October 14, 2009

Roche Gains Access to Cerep’s Pharmacology and ADME Database

  • Roche has inked a deal to use Cerep’s BioPrint®, a homogenous pharmacology and ADME database. The BioPrint database is composed of three main data sets: chemical descriptors (structures and chemical information, 2-D and 3-D descriptors), in vitro profiles, and in vivo effects of tested compound.

    Cerep will also generate new BioPrint® data on Roche compounds for Roche’s exclusive use. Additionally, the companies will collaborate on further development of BioPrint® and related pharmaco-informatics tools aimed at predicting as early as possible adverse drug reactions that could lead to clinical trial failures. 


Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.